AU2021367300A1 — Ampule crush tool
Assigned to Verrica Pharmaceuticals Inc · Expires 2023-04-20 · 3y expired
What this patent protects
Tools (100) for crushing an ampule (146) contained within an applicator (102) for a therapeutic are disclosed herein. The ampule crush tool may be configured to rest on an incline relative to a flat surface. Further, the ampule crush tool may include a spill reservoir (122) for c…
USPTO Abstract
Tools (100) for crushing an ampule (146) contained within an applicator (102) for a therapeutic are disclosed herein. The ampule crush tool may be configured to rest on an incline relative to a flat surface. Further, the ampule crush tool may include a spill reservoir (122) for collecting a volume of the therapeutic expelled during an ampule crushing operation. Additionally, the ampule crush tool may form a fully enclosed cavity such that the ampule crush tool may contain the therapeutic even when the therapeutic is expelled from the ampule along an unpredictable trajectory. The ampule crush tool may also be shaped to orient an ampule-containing applicator in a suitable orientation within the ampule crush tool.
Drugs covered by this patent
- Ycanth (CANTHARIDIN) · Verrica Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.